aod9604 wada prohibited list status 2025 publishes WADA's 2025 Prohibited List Now

There is no FDA-approved indication for any patient population

This is not equivalent to the FDA granting approval as a therapeutic drug, and it carries no standing under UK or EU medicines law

The peptide enhances fat oxidation while preserving lean muscle mass, making it valuable for body recomposition goals

Half-life & frequency rationale No published human pharmacokinetic study of 5-Amino-1MQ exists, and the mouse efficacy study itself did not report half-life or bioavailability figures

Over the course of several weeks, you could gain muscle mass and lose weight more rapidly

Semaglutide works by stimulating a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake